Board of Directors meeting for the approval of the draft financial statements for the year ended 31 December 2025 and the consolidated financial statements as of 31 December 2025.

Ordinary Shareholders’ Meeting for the approval of the financial statements for the year ended 31 December 2025 and the acknowledgement of the consolidated financial statements as of 31 December 2025.

Board of Directors meeting for the approval of the consolidated half-year financial report as of 30 June 2026, voluntarily subject to limited audit review.